<DOC>
	<DOCNO>NCT01285336</DOCNO>
	<brief_summary>This study valuable understanding role DNA repair system play progression rheumatoid arthritis development new therapeutic modality future .</brief_summary>
	<brief_title>The Genetic Functional Study DNA Repair System Susceptibility Rheumatoid Arthritis</brief_title>
	<detailed_description>Rheumatoid arthritis ( RA ) symmetric polyarticular arthritis primarily affect small diarthrodial joint hand foot . In addition inflammation synovium , joint lining , aggressive front tissue call pannus invades destroy local articular structure . The synovium normally relatively acellular structure delicate intimal lining . RA also chronic autoimmune disease lead deformity severe disability , due irreversible damage tendon , joint , bone . It know RA consider complex genetic disease many `` disease-risk '' gene `` disease-protective '' gene involve . Numerous study report association IL-6 , IL-8 gene systemic lupus erythematosus ( SLE ) association HLA-DR gene polymorphism RA . In addition , chronic inflammatory process RA mediate cytokine network , lead induce destructive enzyme , like matrix metalloprotieases , cellular synovial tissue joint . Although RA common arthritis prevalence 1 % Taiwan , pathogenesis still incompletely study , especially DNA repair relative gene . In proposal , would like perform follow experiment : 1 . Study association polymorphisms DNA repair relative gene susceptibility RA ; 2 . Study association copy number variation ( CNV ) DNA repair relative gene susceptibility RA ; 3 . Functional assay DNA repair relative gene compare copy number variation ( CNV ) , genotype and/or haplotype RA patient ; So far , analyzed association RA several SNPs MUTYH DNA repair system . We also analyze relationship SNPs result RA use pathological feature . These data helpful clarify susceptibility RA patient genotype and/or haplotype DNA repair system . This study valuable understanding role DNA repair system play progression rheumatoid arthritis development new therapeutic modality future .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<criteria>Participant sing consent form . Participant 18 year old .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Rheumatoid arthritis ( RA )</keyword>
	<keyword>DNA repair system</keyword>
	<keyword>polymorphism</keyword>
	<keyword>susceptibility</keyword>
	<keyword>copy number variation ( CNV )</keyword>
</DOC>